25
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Effect of the COVID‐19 pandemic on female sexual behavior

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          To evaluate the effect of the COVID‐19 pandemic on female sexual behavior in women in Turkey.

          Methods

          An observational study using data from a previous study conducted prior to the pandemic. We compared frequency of sexual intercourse, desire for pregnancy, Female Sexual Function Index (FSFI) score, contraception type, and menstrual abnormalities among women during the pandemic with 6–12 months prior to the pandemic. Participants were contacted by telephone for questioning.

          Results

          Average frequency of sexual intercourse was significantly increased during the pandemic compared with 6–12 months prior (2.4 vs 1.9, P=0.001). Before the pandemic 19 (32.7%) participants desired to become pregnant, whereas during the pandemic it had decreased to 3 (5.1%) ( P=0.001). Conversely, use of contraception during the pandemic significantly decreased among participants compared with prior (24 vs 10, P=0.004). Menstrual disorders were more common during the pandemic than before (27.6% vs 12.1%, P=0.008). Participants had significantly better FSFI scores before the pandemic compared with scores during the pandemic (20.52 vs 17.56, P=0.001).

          Conclusion

          Sexual desire and frequency of intercourse significantly increased during the COVID‐19 pandemic, whereas quality of sexual life significantly decreased. The pandemic is associated with decreased desire for pregnancy, decreased female contraception, and increased menstrual disorders.

          Abstract

          Sexual desire and frequency of sexual intercourse increased significantly in women during the COVID‐19 pandemic, whereas quality of sexual life decreased significantly.

          Related collections

          Most cited references14

          • Record: found
          • Abstract: found
          • Article: not found

          The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function.

          This article presents the development of a brief, self-report measure of female sexual function. Initial face validity testing of questionnaire items, identified by an expert panel, was followed by a study aimed at further refining the questionnaire. It was administered to 131 normal controls and 128 age-matched subjects with female sexual arousal disorder (FSAD) at five research centers. Based on clinical interpretations of a principal components analysis, a 6-domain structure was identified, which included desire, subjective arousal, lubrication, orgasm, satisfaction, and pain. Overall test-retest reliability coefficients were high for each of the individual domains (r = 0.79 to 0.86) and a high degree of internal consistency was observed (Cronbach's alpha values of 0.82 and higher) Good construct validity was demonstrated by highly significant mean difference scores between the FSAD and control groups for each of the domains (p < or = 0.001). Additionally, divergent validity with a scale of marital satisfaction was observed. These results support the reliability and psychometric (as well as clinical) validity of the Female Sexual Function Index (FSFI) in the assessment of key dimensions of female sexual function in clinical and nonclinical samples. Our findings also suggest important gender differences in the patterning of female sexual function in comparison with similar questionnaire studies in males.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Novel coronavirus infection during the 2019–2020 epidemic: preparing intensive care units—the experience in Sichuan Province, China

            Up to 31 January 2020, there have been 9811 officially reported confirmed cases of 2019-novel coronavirus (nCoV) infection in China since the epidemic began in December 2019 (updated data available at https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6). With the rapid transmission, the epidemic has spread throughout the country, and 177 cases have been reported in Sichuan Province. As nCoV infection is a highly contagious disease with high mortality (3–15%) [1–3] and West China Hospital (WCH) is the largest hospital in the southwest of China and the referral medical center in Sichuan Province, it is our responsibility to prepare for admission of additional critically ill patients as a matter of emergency. We have held several expert meetings and have reviewed the related literature to develop a plan to respond to the epidemic [4, 5]. The purpose of the plan is to enable us to provide the maximum level of care to critically ill patients while ensuring the protection of medical staff. Novel coronavirus infection special intensive care team We set up a special emergency multi-disciplinary intensive care team to discuss the problems that we might encounter and countermeasures. Team members include intensive care unit (ICU) physician, infectious disease physician, nurse, respiratory therapist, nosocomial infection control expert, and administrative staff. We first evaluated the isolation conditions and the capacity of our department to admit a larger number of patients. Second, we specified the protection levels for different types of health care activities. Third, we assigned special work such as patient screening, consultation, and transfer to designated staff to minimize the number of health workers who had contact with patients with nCoV infection. Bed and medical equipment preparation WCH is a teaching hospital with 4300 total beds and 8 ICUs of total 206 ICU beds. Under normal conditions, the ICU bed usage is always above 90%. It was not appropriate to treat 2019-nCoV-infected patients in the central area because the large stream of people would have a negative impact on infection control measures to curb the spread of the infection. The hospital authorities decided to vacate 402 beds belonging to the Center of Infectious Disease and the adjacent Fifth Inpatient Building so that both are separated from the rest of the inpatient buildings in WCH (Supplementary Figure 1). Based on the initial data [1, 2] and taking into consideration the surge of critically ill patients, we plan to equip 50 ICU beds initially and adjust on the number of patients, as necessary. We made a list of requirements for other special medical equipment, such as ventilators, bronchoscopes, hemodialysis machines, ultrasound machines, standard personal protective equipment (PPE), and sterilizing equipment. During this epidemic period, a large amount of certified PPE, including medical masks, goggles, face shields, and waterproof isolation gowns, is required. Manufactures of the items on the requirement list were contracted and we drew up an advertisement to the society calling for donations to ensure sufficient supplies. Education and training of staff It is very important to make all staff aware of the public health significance of the epidemic, and of potential challenges in achieving disease control. Strict isolation and protection measures are a top priority. Training content includes hand and respiratory hygiene, use of PPE, safe waste management, environmental cleaning, and sterilization of patient-care equipment [6]. We educate and train staff by means of presentations, short videos, WeChat, and supervision to ensure that staff are following the correct procedures. Protection of medical staff A special access to patients was set up and a boundary between the ward in which the nCoV patients are being treated and the office and living area of medical staff was established. The aim was to minimize the number of medical staff that have contact with a patient at any time, including during daily care, treatment, and transfer; minimize the use of high transmission-risk procedures such as bronchoscopy, manual ventilation, non-invasive ventilation, and tracheotomy. We use airborne precautions if these operations are necessary. Diagnostic imaging procedures such as X-ray and ultrasound at the bedside are prioritized, restricting computed tomography (CT) scans, because they cannot be performed at the bedside. Early case recognition and classification of disease severity A physiological parameter-based warning score is used to facilitate early recognition of patients with severe infection and admission decisions according to the severity classification. The score is a modified version of the National Early Warning Score (NEWS) with age ≥ 65 years added as an independent risk factor based on recent reports [7, 8] (Fig. 1). Fig. 1 Early warning score and rules for 2019-nCoV infected patients. *CCRRT: Critical Care Rapid Response Team Patients are divided into four risk categories based on the score: low, median, high, and exceptional. A specially assigned physician or the special critical care team decides which patients need to be treated in the ICU, taking into consideration the disease severity, opportunity to benefit, and sources of support (Fig. 1). Strict restriction of patient contact All staff are required to report any history of exposure, respiratory symptoms, and temperature before entering the building in which the nCoV patients are treated. Everyone must wear masks, isolation suits, and wash hands if need to be in the building. Family members and non-essential medical staff are strictly forbidden from entering the nCoV ward. Research As nCoV infection is a novel disease, knowledge about it is limited [9, 10], especially regarding the management of critically ill patients. We designed a case report form to collect clinical data, proceed with the ethics committee approval of research protocols, and contact with the laboratory that is qualified to conduct research on highly infectious organisms. In conclusion, the 2019-nCoV epidemic is a threat, not only to China, but also to global health. As ICU physicians, our focus is on the management of the most severe patients. We are unable to predict how many critically ill patients we will receive but are doing the best that we can to be prepared and to work together to overcome the epidemic. Electronic supplementary material Below is the link to the electronic supplementary material. Supplementary file1 (JPG 7082 kb)
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Preparedness and proactive infection control measures against the emerging novel coronavirus in China

              Sir, In response to the official announcement of a cluster of pneumonia of unknown aetiology with an epidemiological link to a wet market in Wuhan, China on 31 December 2019 [1], we present our proactive infection control measures for immediate prevention against hospital outbreaks due to such imported cases into Hong Kong. Hong Kong is a cosmopolitan city in south China with a unique history of confirming the first case of human infection due to avian influenza A H5N1 in 1997 [2] and severe acute respiratory syndrome (SARS)-associated coronavirus (CoV) in 2003 [3]. Patients with H5N1 and SARS-CoV initially presented with either community- or hospital-acquired pneumonia of unknown aetiology, and did not respond to broad-spectrum antimicrobial therapy with typical and atypical coverage. Epidemiological exposure to wet markets with contact with poultry and civet, respectively, was subsequently recognized as a risk factor for acquisition of novel pathogens [3]. Based on our previous experiences with novel respiratory infections, we recognize the utmost importance of infection control preparedness in our healthcare system. Our preparedness levels includes alert, serious level 1, serious level 2 and emergency; the level of activation is determined according to a risk assessment. Infection control measures and administrative support are enhanced with reference to the different levels of preparedness. With this infrastructure, we overcame the challenge of pandemic influenza A in 2009 [4,5] and the emergence of avian influenza A H7N9 in 2013 [6,7]. To prepare for this emerging infectious disease, fever screening has been set up at the airport and high-speed rail station, focusing particularly on flights and trains from Wuhan. Travellers with fever ≥38oC are referred to public hospitals for assessment. In the public hospital system, the key measures include a surveillance system to identify suspected cases for early isolation in an airborne infection isolation room (AIIR). Standard, contact, droplet and airborne precautions are implemented during patient care practices for the suspected cases, before the mode of transmission is known. The surveillance definition comprises clinical criteria (any patient with fever and acute respiratory illness, or pneumonia) plus a travel history to Wuhan in the 14 days before onset of symptoms, irrespective of any wet market exposure. For the purpose of surveillance, triage stations have been set up in the accident and emergency departments (AEDs) and outpatient clinics, where personal protective equipment (PPE) includes surgical mask, face shield or equivalent, and gown as minimum. Patients fulfilling the clinical and epidemiological criteria are isolated immediately in an AIIR for further assessment. Face-to-face right-on-time education has been provided for frontline healthcare workers in the AEDs, acute medical wards, isolation wards, intensive care units, general wards, ambulatory day centres, physiotherapy, occupational therapy and pharmacy. In addition, open staff forums were provided during the first week of preparedness in the hospitals. During the training sessions, staff were reminded to be alert to the identification of suspected cases, and to use infection control measures by wearing an N95 respirator, face shield or equivalent, gloves and gown when performing aerosol-generating procedures on all patients in both AIIRs and general wards, in case suspected patients had been missed by the surveillance system. In addition, the opportunity was taken to remind staff of the administrative support of the hospital preparedness plan for emerging infectious diseases, including waste and linen management, environmental cleaning and supply of PPE. Before identification of the aetiological agent, the diagnostic strategy includes a two-tier approach. The first tier is to screen the upper respiratory specimen (nasopharyngeal aspirates or nasopharyngeal flocked swab) by Biofire (FilmArray Respiratory Panel 2), which is a molecular diagnostic test to detect 17 respiratory viruses and four bacteria in 1 h. The second tier is to investigate the FilmArray RP2-negative specimen for pan-CoV polymerase chain reaction (PCR) [8] with modification in order to detect 23 CoVs known to be present in humans, animals and bats within 24 h. Pan-CoV PCR-negative specimens would be further investigated by performing Nanopore sequencing to identify the novel agent. Within the first 10 days of surveillance and this testing strategy, 55 patients fulfilling the surveillance criteria were admitted to hospitals in Hong Kong; none have tested positive for the novel agent to date. A novel CoV was identified in patients with pneumonia in Wuhan within 1 month of outbreak. This was faster than the time required to identify SARS-CoV (Table I ) [3]. The viral genome (GenBank Accession No. MN908947) has the highest similarity (89%) to a SARS-related member of the Sarbecoviruses (MG772933), a subgenus within the Betacoronavirus genus. However, the transmissibility, morbidity and mortality of this novel CoV remain unresolved. Without the availability of effective antiviral therapy and vaccine, we have to be vigilant in enforcing infection control preparedness and measures to prevent importation of index patients and minimize the risk of nosocomial transmission. Table I Comparison of public health response and discovery of aetiological agent between severe acute respiratory syndrome (SARS)-associated coronavirus (CoV) and a novel CoV in China Table I SARS-CoV Novel CoV Date of first reported case (retrospective analysis) 16 November 2002 [3] 8 December 2019a Location of first reported case Foshan, Guangdong Province, China [3] Wuhan, Hubei Province,Chinaa Date of first report on social media End of December 2002 30 December 2019b Date of first release by health official in China 11 February 2003c 31 December 2019d , e Date of first official response from Department of Health, HKSAR 11 February 2003f 31 December 2019g Date of discovery of novel agent 21 March 2003 [3] 9 January 2020h Location of discovery of novel agent Hong Kong [3] Chinah , i Time from first reported case to official report of outbreak (days) 87 23 Time from first reported case to discovery of novel agent (days) 125 32 HKSAR, Hong Kong Special Administrative Region, China. a https://www.ecdc.europa.eu/en/news-events/update-cluster-pneumonia-cases-associated-novel-coronavirus-wuhan-china-2019 [last accessed January 2020]. b https://www.japantimes.co.jp/news/2019/12/31/asia-pacific/science-health-asia-pacific/outbreak-sars-like-pneumonia-investigated-china/ [last accessed January 2020]. c World Health Organization receives reports from the Chinese Ministry of Health of an outbreak of acute respiratory syndrome with 300 cases and five deaths in Guangdong Province. Available at: https://www.who.int/csr/don/2003_07_04/en/ [last accessed January 2020]. d https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en/ [last accessed January 2020]. e http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989 [last accessed January 2020]. f https://www.dh.gov.hk/english/press/2003/03_02_11.html [last accessed January 2020]. g https://www.info.gov.hk/gia/general/201912/31/P2019123100667.htm [last accessed January 2020]. h https://www.sciencemag.org/news/2020/01/mystery-virus-found-wuhan-resembles-bat-viruses-not-sars-chinese-scientist-says [last accessed January 2020]. i https://www.sciencemag.org/news/2020/01/chinese-researchers-reveal-draft-genome-virus-implicated-wuhan-pneumonia-outbreak [last accessed January 2020]. Conflict of interest statement None declared. Funding sources None.
                Bookmark

                Author and article information

                Contributors
                baharyl86@gmail.com
                Journal
                Int J Gynaecol Obstet
                Int J Gynaecol Obstet
                10.1002/(ISSN)1879-3479
                IJGO
                International Journal of Gynaecology and Obstetrics
                John Wiley and Sons Inc. (Hoboken )
                0020-7292
                1879-3479
                23 May 2020
                July 2020
                23 May 2020
                : 150
                : 1 , SPECIAL SECTION: FROM THE FIGO PRETERM BIRTH WORKING GROUP ( doiID: 10.1002/ijgo.v150.1 )
                : 98-102
                Affiliations
                [ 1 ] Department of Obstetrics and Gynecology Esenler Maternity and Children’s Hospital Istanbul Turkey
                [ 2 ] Department of Urology Haseki Teaching and Research Hospital Istanbul Turkey
                Author notes
                [*] [* ] Correspondence

                Bahar Yuksel, Esenler Maternity and Children’s Hospital, Esenler, Istanbul, Turkey.

                Email: baharyl86@ 123456gmail.com

                Article
                IJGO13193
                10.1002/ijgo.13193
                9087619
                32392400
                fe2dde67-1684-4df6-a10b-66cfc56a77c4
                © 2020 International Federation of Gynecology and Obstetrics

                This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.

                History
                : 23 April 2020
                : 20 April 2020
                : 06 May 2020
                Page count
                Figures: 0, Tables: 3, Pages: 5, Words: 3251
                Categories
                Clinical Article
                Clinical Articles
                Gynecology
                Custom metadata
                2.0
                July 2020
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.1.5 mode:remove_FC converted:10.05.2022

                Obstetrics & Gynecology
                coronavirus,covid‐19,female sexual function index (fsfi),pandemic,sars‐cov‐2,sexual behavior,turkey

                Comments

                Comment on this article